x |
| Revenue for Albany Molecular Research Decreases by -4.86% even though Revenue for Medical Labs and Research Industry Increases by 2.51% over Latest 12 Months |
|
Stock Quote: (NasdaqNM:AMRI) |
| 11/16/2009 |
|
| 8.74 |
 +0.10 |
+1.16% |
193,176 |
|
| Revenue for Albany Molecular Research Decreases by -4.86% even though Revenue for Medical Labs and Research Industry Increases by 2.51% over Latest 12 Months |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 16, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for Albany Molecular Research (NASDAQ:AMRI) for its twelve months ended September 30, 2009 decreased by -4.86% to ... read full story |
|
|
|
